(Q83198101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

The natural course of progressive systemic sclerosis patients with interstitial lung involvement (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Musellim Benan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ikitimur Hande

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ongen Gul

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

25 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

349-354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0302-6

Pulmonary manifestations of scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0302-6

The pulmonary manifestations of scleroderma; an anatomic-physiological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0302-6

D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0302-6

Observations on the use of prednisone in patients with progressive systemic sclerosis (diffuse scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0302-6

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0302-6

An epidemiological study of scleroderma in the West Midlands

21 January 2018

1 reference

12 December 2020

The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology

1 reference

12 December 2020

Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.

1 reference

12 December 2020

Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

1 reference

12 December 2020

1 reference

12 December 2020

A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis

1 reference

12 December 2020

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

12 December 2020

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

12 December 2020

European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Methotrexate treatment in scleroderma

1 reference

12 December 2020

The effect of D-penicillamine on pulmonary findings in systemic sclerosis.

1 reference

12 December 2020

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

12 December 2020

Enlarged mediastinal lymph nodes in the fibrosing alveolitis of systemic sclerosis

1 reference

12 December 2020

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

1 reference

12 December 2020

Increased prevalence of symptomatic macrovascular disease in systemic sclerosis

1 reference

12 December 2020

African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease

1 reference

12 December 2020

Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment

1 reference

12 December 2020

The natural history of progressive systemic sclerosis (diffuse scleroderma)

1 reference

12 December 2020

Successful treatment of far-advanced progressive systemic sclerosis by D-penicillamine

1 reference

12 December 2020

A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment]

1 reference

12 December 2020

Severe restrictive lung disease in systemic sclerosis.

1 reference

12 December 2020

Two years of penicillamine for progressive systemic sclerosis: a case report

1 reference

12 December 2020

Low dose methotrexate treatment in systemic sclerosis

1 reference

12 December 2020

Scleroderma in South Australia: epidemiological observations of possible pathogenic significance

1 reference

12 December 2020

D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study

1 reference

12 December 2020

Interstitial lung disease in scleroderma

1 reference

12 December 2020

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

12 December 2020

Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis

1 reference

12 December 2020

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

12 December 2020

Systemic sclerosis in Iceland. A nationwide epidemiological study

1 reference

12 December 2020

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma

1 reference

12 December 2020

10.1007/S10067-006-0302-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference